MONOCLONAL-ANTIBODIES IN CANCER-THERAPY

被引:73
作者
RIETHMULLER, G
SCHNEIDERGADICKE, E
JOHNSON, JP
机构
[1] TUMORZENTRUM, D-80337 MUNICH, GERMANY
[2] INST IMMUNOL, D-80336 MUNICH, GERMANY
关键词
D O I
10.1016/0952-7915(93)90129-G
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A review of the clinical trials of antibody based cancer therapies reveals that this approach can, in rare cases, induce complete remissions in individual patients with cancer. Since these trials have usually involved patients with large tumor masses, tumor cell inaccessibility is probably a major reason for the prevailing failures. Minimal residual disease, the stage when tumor cells are few and dispersed, should therefore be a more promising target for therapeutic antibodies. This hypothesis is supported by a prospective randomized trial on patients with resected Dukes C colorectal carcinoma that resulted in increased survival and prolonged recurrence-free intervals. Thus, in addition to strategies designed to produce more effective, human-derived reagents, efforts need to be concentrated on directing passive antibody therapy towards the appropriate target.
引用
收藏
页码:732 / 739
页数:8
相关论文
共 66 条
[1]  
BACUS SS, 1992, CANCER RES, V52, P2580
[2]   SEMISYNTHETIC COMBINATORIAL ANTIBODY LIBRARIES - A CHEMICAL SOLUTION TO THE DIVERSITY PROBLEM [J].
BARBAS, CF ;
BAIN, JD ;
HOEKSTRA, DM ;
LERNER, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) :4457-4461
[3]  
BARKER E, 1993, CANCER RES, V53, P362
[4]  
Billetta R, 1993, Int Rev Immunol, V10, P165, DOI 10.3109/08830189309061693
[5]  
BONARDI MA, 1992, INT J CANCER, P73
[6]   A RECOMBINANT IMMUNOTOXIN THAT IS ACTIVE ON PROSTATE-CANCER CELLS AND THAT IS COMPOSED OF THE FV REGION OF MONOCLONAL-ANTIBODY PR1 AND A TRUNCATED FORM OF PSEUDOMONAS EXOTOXIN [J].
BRINKMANN, U ;
GALLO, M ;
BRINKMANN, E ;
KUNWAR, S ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :547-551
[7]  
Carrel Stefan, 1993, Current Opinion in Oncology, V5, P383, DOI 10.1097/00001622-199303000-00018
[8]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[9]  
CURTI BD, 1993, CANCER RES, V53, P2204
[10]   DETECTION OF TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PRIMARY BREAST-CANCER - A PROGNOSTIC FACTOR FOR DISTANT METASTASIS [J].
DIEL, IJ ;
KAUFMANN, M ;
GOERNER, R ;
COSTA, SD ;
KAUL, S ;
BASTERT, G .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (10) :1534-1539